Services for medicinal products and healthcare products
“With our new, more streamlined corporate structure, we are now prepared for sustained growth over the next 25 years,” explains Martin Vortkamp, new member of the executive board of Diapharm GmbH & Co. KG. Together with Ralf Sibbing, he will guide the fortunes of approximately 100 members of staff in the fields of Regulatory Affairs, Quality Management, Medical & Clinical and Business Development. Martin Vortkamp was previously Director of Regulatory Affairs and Business Development at Diapharm. The company supports players within the medicinal product and healthcare product industry in all regulatory, medical and pharmaceutical questions concerning medicinal products, medical devices, food supplements and cosmetics.
(approx. 1,475 characters)